This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The UC SanDiego Health System has developed a diagnostic test that can determine whether a patient has contracted the novel coronavirus in about eight hours.
After an extensive review of the many nominees for the first-ever Xconomy Awards SanDiego, Xconomy editors across the country and a panel of local experts together narrowed the list to 42 finalists (listed below) across eight categories. The winner of our Lifetime Achievement award will be revealed later this spring.
Local biotech executives and investors shared snapshots of life sciences in the time of coronavirus Wednesday afternoon at Xconomy’s Xcelerating Life Sciences SanDiego event. The program, originally slated to take. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.
The nominees and finalists for the first-ever Xconomy Awards SanDiego were an impressive bunch, making it tough for our judges and the editors to pick the winners. After much discussion and debate, we decided that these winners represent the best of the SanDiego life sciences and healthtech community.
However, the company's technology team, Walmart Labs (www.walmartlabs.com)--which said this month that it is planning on major growth in SanDiego is responsible for the company's key supply chain technology, online e-commerce site, and much more. What exactly does Walmart Labs work on in SanDiego?
However, the company's technology team, Walmart Labs (www.walmartlabs.com)--which said this month that it is planning on major growth in SanDiego is responsible for the company's key supply chain technology, online e-commerce site, and much more. What exactly does Walmart Labs work on in SanDiego?
View the Slideshow We at Xconomy were thrilled to see such a great turnout at our first-ever awards gala in SanDiego. About 250 people from the local life sciences community filled a ballroom at Estancia La Jolla Hotel & Spa (see photos above).
We at Xconomy are excited to announce that we are honoring Ivor Royston , co-founder of Hybritech and Idec Pharmaceuticals, with our 2019 Lifetime Achievement Award—the first ever awarded in SanDiego. He will receive his award and give a talk reflecting on his career at our inaugural Xconomy Awards SanDiego gala on May.
In the eyes of the SanDiego Venture Group, the key element is readiness for venture capital backing. What does it take for a tech startup to be considered “cool?”
Each of the finalists in the CEO category for the first-ever Xconomy Awards SanDiego program have shown this kind of mettle. Here’s an introduction to each chief executive who made the. Read more » Reprints | Share:
Summer can be a slow time in SanDiego, but its startups have stayed busy. Based in Carlsbad, in northern SanDiego County, Ezoic launched its platform in 2011. Read on for news of recent financings, plus upcoming opportunities to connect with the local tech community.
SanDiego has long been considered a second-tier primary biopharma hub in terms of number of companies and venture capital raised, falling behind the twin behemoths of Boston-Cambridge and the San Francisco Bay Area on those and other metrics.
Let’s catch up with the latest tech news in SanDiego. —SanDiego’s AON Devices was among 10 startups selected to compete at a recent pitch competition hosted by the corporate venture capital arm of Qualcomm (NASDAQ: QCOM ).
Every year my family meets in SanDiego for Thanksgiving. Panic ensued as we couldn’t bring the dogs to SanDiego and my brother’s three kids look forward to this great trip all year. ” She arrived late that night in SanDiego. The photo in this blog (like many of mine) came from 500px.
SanDiego’s startup community has rejoiced in recent months as massive companies that employ thousands of engineers—including Amazon (NASDAQ: AMZN ), Apple (NASDAQ: AAPL ), and the tech arm of Walmart (NYSE: WMT )—have announced expansions in the region.
Learn what’s fueling SanDiego’s biotech investment and partnership opportunities by downloading Xconomy’s new special report and podcast that package the highlights from the recent Xcelerating Life Sciences SanDiego: Biomedical Breakthroughs in Precision Medicine & Genomics event.
I owe ya’ a 20 minute call (or in person next time I’m in SanDiego). Brad on blogging. How did you start blogging? “My Huge thank you to Steve De Long for the write up. The following is a brief series of quotes from just ten of the approximately 30 different topics discussed in this incredible interview.
Headed by president and CEO Niall O’Donnell (pictured), the SanDiego-based company launched last year with $50 million and an investigational small molecule drug it licensed from High Point, NC-based vTv Therapeutics (NASDAQ: VTVT ). The molecule, REN001, is being developed for patients with primary mitochondrial myopathies (PMM).
Mission Edge, a nonprofit organization backed by the SanDiego Foundation and three corporations, has chosen 10 companies and organizations to participate in a 12-week program intended to improve each entity’s financial performance, and thereby long-term sustainability. Ken Davenport, CEO of SanDiego-based Mission.
Founders Jared Tagney and Joshua Windmiller, who met while in grad school at UC SanDiego, started the company in 2012 as Electrozyme. The SanDiego startup. The company began focusing on the technology it is currently developing in 2015, Tagney said. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.
At the start of 2020 thousands of biotechies anticipated spending the second week of June in SanDiego, hobnobbing at the annual conference hosted by the Biotechnology Innovation Organization. Instead, attendees from 64 countries spanning 28 times zones convened online this week for the first-ever virtual BIO International Convention.
Building on the popularity and strength of the 2017-2019 Boston Xconomy Awards and the 2019 SanDiego Xconomy Awards, the 2020 National Xconomy Awards winners will be announced at a Monday, June 8 gala at the Hard Rock Hotel SanDiego during. Submit yours today.
The first business accelerator program in southeast SanDiego is accepting applications for its second cohort of entrepreneurs, who would start the program in fall. Connect All debuted this year with the mission of supporting diverse and lower-income entrepreneurs. Read more » Reprints | Share:
The SanDiego biotech on Monday announced it had received the FDA’s OK to enter into the clinic with ARCT-810, an investigational treatment for ornithine transcarbamylase (OTC) deficiency , a rare inherited disease that causes dangerous levels of ammonia to accumulate in the body.
SanDiego has had plenty of businesses go public in recent years, but most have been life sciences companies. Now software startup Tealium, which has about 215 employees at its SanDiego headquarters, announced Wednesday it has added $55 million in a Series F financing.
Now the SanDiego-based company has added $53 million to a round of funding it first closed in 2017, money that it plans to put toward continued evaluation of the investigational antifungal treatment, fosmanogepix.
However, that wasn’t the problem SanDiego startup LabFellows was looking to solve when it launched in 2014. Scientists, no matter how sexy the research they’re conducting, aren’t immune from the administrative minutiae of office life. Such tasks steal time away from researchers’ main objectives.
A group of scientists and physicians at UC SanDiego Health and the UCSD School of Medicine has arranged a partnership with five diagnostics markers that it says will bring the health system’s capacity to test for coronavirus to as many as 1,500 tests daily sometime in early April.
A SanDiego startup says it has adapted the blockchain technology that underpins digital currencies like Bitcoin for use as a distributed database for genomic information.
Advancing new forms of birth control is a central focus at Daré Bioscience (NASDAQ: DARE ), a SanDiego-based biopharma company that’s built a pipeline of experimental devices and treatments tailored for women’s health. Order groceries? Turn off the bedroom lights? How about contraception?
The venture investment, which the SanDiego startup announced Tuesday, is one of only a few so-called mega-rounds—$100 million or more—recorded this year in the region. (In Thompson to its board of directors. In Southern California, rounds that large are more often raised by life sciences companies.)
The Plymouth Meeting, PA-based company, which also conducts research in SanDiego, plans to enroll as many as 40 adults across two trial locations. Inovio Pharmaceuticals, one of the biotechs developing a vaccine to prevent COVID-19, has received the FDA’s OK to start testing its candidate in healthy volunteers.
Louis, MO-based venture capital firm with additional offices in SanDiego, CA, and Cleveland, OH, has raised $184.4 RiverVest Venture Partners, a St. million for its fourth fund dedicated to investing in healthcare companies. Since its launch, RiverVest has invested in 47 companies working to develop new drugs and medical devices.
Eight years after SanDiego biotech Prometheus Laboratories was acquired by Nestlé Health Science , the diagnostic business has been sold again, this time to a little-known biotech called Precision IBD that plans to lay off approximately a quarter of Prometheus’s workforce.
In return, SanDiego-based Neurocrine will gain rights to Voyager’s. Neurocrine (NASDAQ: NBIX ) has agreed to pay Voyager (NASDAQ: VYGR ) $115 million in cash and buy $50 million worth of the Cambridge, MA, company’s shares at $11.96 apiece—a roughly 50 percent premium to its $8.04 closing price on Monday.
The SanDiego-area medical research institute inked a similar deal with the Mayo Clinic in 2012. The partnership is part of a broader movement to accelerate the “bench to bedside” process by better integrating those in academia, government, and industry in the hopes of more rapidly pushing ahead pharmaceutical innovation.
The SanDiego company, which has touted its product candidates as safer than early-generation versions developed by other companies, announced the FDA’s decision to pause the study on Monday.
Biotech veterans Tom Farrell and Peter Flynn have teamed up to start a new SanDiego company that aims to develop allogeneic, or off-the-shelf, cell-based immunotherapies using natural killer (NK) cells that can be manufactured at scale and delivered to cancer patients outside of the hospital.
GreatCall, the maker of the Jitterbug cellphone and other products and services for older adults, has extended its partnership with the San Francisco-based ride-hailing company Lyft to offer GreatCall customers the ability to schedule rides without a smartphone app. No financial terms were disclosed.
However, the SanDiego-based company, which emerged from stealth mode in 2016, was guided through its early years by president and CEO Stephan Chenette. AttackIQ said Galloway is taking over the role from Carl Wright, who has been named chief commercial officer. Wright was hired as chief revenue officer in August 2017.
In 2017 the SanDiego area-based biotech made the first step in its transformation into a drug development-focused organization, licensing rights to an investigational cancer drug from Italy’s Nerviano Medical Sciences.
The event is one of the most popular showcases of SanDiego-area tech innovation, and it usually provides an interesting local snapshot of industry trends. EvoNexus typically hosts a “Demo Day” event twice per year to highlight the top startups currently housed in its incubator.
SanDiego-based La Jolla (NASDAQ: LJPC ) has pledged to pay Tetraphase shareholders $43 million in cash now plus another $16 million tied to sales goals for Tetraphase (NASDAQ: TTPH ) antibiotic eravacycline (Xerava). The competition for Tetraphase Pharmaceuticals now has a new winner : La Jolla Pharmaceutical.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content